


We harness the thermal and mechanical effects
of focused ultrasound to explore new indications,
drug modalities, and our product portfolio.
Our global collaborations with clinical centers, researchers,
and the Focused Ultrasound Foundation help bring research
through clinical development to commercialization.
We develop innovative therapies and products
through expertise that spans focused ultrasound
device development and clinical application.
Our Journey from Research to Global Clinical Trials
2010
Foundation of IMGT
Beginning of FUS Development
2022
ISO 9001:2015 Certification
Establishment of a Global QMS
2024
IR52 Jang Young‑sil Award
Recognition for R&D Excellence
2025
FDA Breakthrough Device Designation (BDD)
Acknowledgment of the Potential to Advance Treatment
2026
Conducting Pivotal Trials in the U.S. and Korea
Key Step toward Regulatory Approval
QUALITY
INNOVATION
FOUNDATION
TECHNOLOGY
DEVELOPMENT